Latest Breaking News On - Fortress biotech company profile - Page 2 : comparemela.com

Insider Buying: Fortress Biotech, Inc (NASDAQ:FBIO) CEO Acquires 10,000 Shares of Stock

Fortress Biotech, Inc. (NASDAQ:FBIO – Get Free Report) CEO Lindsay A. Md Rosenwald bought 10,000 shares of Fortress Biotech stock in a transaction that occurred on Thursday, May 16th. The stock was bought at an average cost of $1.76 per share, with a total value of $17,600.00. Following the completion of the purchase, the chief […]

Roth mkmVirtu financialAlliance global partnersSecurities exchange commissionAcadian asset managementFortress biotech company profileAsset management corpShikiar asset management incFortress biotech incFortress biotechGet free reportExchange commissionGlobal partnersAsset managementManagement corpFortress biotech daily

Fortress Biotech, Inc Declares Monthly Dividend of $0 20 (NASDAQ:FBIOP)

Fortress Biotech, Inc Declares Monthly Dividend of $0 20 (NASDAQ:FBIOP)
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Fortress biotech incFortress biotech company profileFortress biotechGet free reportFortress biotech daily

Fortress Biotech, Inc (NASDAQ:FBIO) Short Interest Up 12 3% in March

Fortress Biotech, Inc (NASDAQ:FBIO) Short Interest Up 12 3% in March
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Roth mkmAlliance global partnersFortress biotech incMorgan stanleyWells fargo companyGladstone institutional advisoryAdvisor group holdings incCharles schwab investment management incFortress biotech company profileFortress biotechGet free reportGroup holdingsInstitutional advisorySchwab investment managementWells fargoFortress biotech daily

Fortress Biotech, Inc (NASDAQ:FBIO) Given Consensus Recommendation of Buy by Analysts

Fortress Biotech, Inc. (NASDAQ:FBIO – Get Free Report) has been assigned a consensus recommendation of “Buy” from the five brokerages that are presently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have issued a report on the stock […]

Roth mkmFortress biotech company profileEnvestnet asset management incSigma securitiesFortress biotech incAdvisor group holdings incWells fargo companyAlliance global partnersFortress biotechGet free reportGlobal partnersGroup holdingsEnvestnet asset managementGet freeFortress biotech daily

Fortress Biotech, Inc (NASDAQ:FBIOP) Announces $0 20 Monthly Dividend

Fortress Biotech, Inc (NASDAQ:FBIOP) Announces $0 20 Monthly Dividend
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Fortress biotech incFortress biotech company profileFortress biotechGet free reportWall street journalFortress biotech daily